Antibody conjugates with unnatural amino acids
- PMID: 25898256
- DOI: 10.1021/acs.molpharmaceut.5b00082
Antibody conjugates with unnatural amino acids
Abstract
Antibody conjugates are important in many areas of medicine and biological research, and antibody-drug conjugates (ADCs) are becoming an important next generation class of therapeutics for cancer treatment. Early conjugation technologies relied upon random conjugation to multiple amino acid side chains, resulting in heterogeneous mixtures of labeled antibody. Recent studies, however, strongly support the notion that site-specific conjugation produces a homogeneous population of antibody conjugates with improved pharmacologic properties over randomly coupled molecules. Genetically incorporated unnatural amino acids (uAAs) allow unique orthogonal coupling strategies compared to those used for the 20 naturally occurring amino acids. Thus, uAAs provide a novel paradigm for creation of next generation ADCs. Additionally, uAA-based site-specific conjugation could also empower creation of additional multifunctional conjugates important as biopharmaceuticals, diagnostics, or reagents.
Keywords: Chinese hamster ovary; antibody−drug conjugate; drug:antibody ratio; heavy chain; light chain; pharmacokinetics; tRNA synthetase; unnatural amino acid.
Similar articles
-
Unnatural amino acids in novel antibody conjugates.Future Med Chem. 2014 Jul;6(11):1309-24. doi: 10.4155/fmc.14.79. Future Med Chem. 2014. PMID: 25163001 Review.
-
Current Status: Site-Specific Antibody Drug Conjugates.J Clin Immunol. 2016 May;36 Suppl 1:100-7. doi: 10.1007/s10875-016-0265-6. Epub 2016 Mar 22. J Clin Immunol. 2016. PMID: 27003914 Free PMC article. Review.
-
Production of site-specific antibody-drug conjugates using optimized non-natural amino acids in a cell-free expression system.Bioconjug Chem. 2014 Feb 19;25(2):351-61. doi: 10.1021/bc400490z. Epub 2014 Jan 29. Bioconjug Chem. 2014. PMID: 24437342
-
Genetically Encoded Azide Containing Amino Acid in Mammalian Cells Enables Site-Specific Antibody-Drug Conjugates Using Click Cycloaddition Chemistry.Bioconjug Chem. 2015 Nov 18;26(11):2249-60. doi: 10.1021/acs.bioconjchem.5b00359. Epub 2015 Sep 11. Bioconjug Chem. 2015. PMID: 26332743
-
Advances in the Development of Site-Specific Antibody-Drug Conjugation.Anticancer Agents Med Chem. 2015;15(7):828-36. doi: 10.2174/1871520615666150302125448. Anticancer Agents Med Chem. 2015. PMID: 25731178 Review.
Cited by
-
Enantioselective organocatalytic strategies to access noncanonical α-amino acids.Chem Sci. 2024 Mar 25;15(16):5832-5868. doi: 10.1039/d4sc01081g. eCollection 2024 Apr 24. Chem Sci. 2024. PMID: 38665517 Free PMC article. Review.
-
Optimal Synthetic Glycosylation of a Therapeutic Antibody.Angew Chem Weinheim Bergstr Ger. 2016 Feb 12;128(7):2407-2413. doi: 10.1002/ange.201508723. Epub 2016 Jan 12. Angew Chem Weinheim Bergstr Ger. 2016. PMID: 27546920 Free PMC article.
-
Genetic Encoding of a Bioconjugation Handle for [2+2+2] Cycloaddition Reactions.Chembiochem. 2020 Feb 3;21(3):310-314. doi: 10.1002/cbic.201900391. Epub 2019 Oct 17. Chembiochem. 2020. PMID: 31298807 Free PMC article.
-
Homogeneous multi-payload antibody-drug conjugates.Nat Chem. 2024 Jun;16(6):854-870. doi: 10.1038/s41557-024-01507-y. Epub 2024 May 17. Nat Chem. 2024. PMID: 38760431 Review.
-
An Antibody-Drug Conjugate for Multiple Myeloma Prepared by Multi-Arm Linkers.Adv Sci (Weinh). 2024 May;11(20):e2307852. doi: 10.1002/advs.202307852. Epub 2024 Mar 13. Adv Sci (Weinh). 2024. PMID: 38477561 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources